FLIBGA REPORT AT THE DEPARTMENT OF NEUROLOGY - UNIVERSITY MEDICAL CENTER, HCM CITY

On April 22, 2026, Medbolide Pharmaceutical JSC participated in a scientific seminar hosted by the Department of Neurology at UNIVERSITY MEDICAL CENTER, HCM CITY. The seminar was attended by doctors and nurses from the Department of Neurology and was chaired by the Department Head, Dr. Nguyen Ba Thang.

At the seminar, Dr. Lê Trí Sĩ presented on the topic: “Vestibular Suppression in Acute Vertigo''. He discussed symptoms such as dizziness and nausea associated with vestibular disorders. He also introduced the active ingredient meclizine—an effective solution for treating acute and severe vestibular disorders.

FLIBGA, containing 25 mg of meclizine, offers the following key benefits: Equivalent efficacy to diazepam; The active ingredient has been FDA-approved since 1957, the first-line treatment for severe vestibular disorders, reduces episodes of dizziness and nausea during the first 7 days of a vestibular disorder.

The presentation garnered significant interest and positive feedback from the doctors regarding the FLIBGA product.

At the conclusion of the session, the company expressed its gratitude and hope to continue partnering with the hospital in providing effective solutions to enhance the quality of patient care. Medbolide Pharmaceutical JSC is proud to be a trusted partner of UNIVERSITY MEDICAL CENTER, HCM CITY  in supplying high-quality, effective medical products that contribute to the healthcare of the community.